It has been shown in previous studies that TAM-derived exosomal miR-501-3p can promote PaCa development through activation of the TGF-β signaling pathway and is a novel molecular target for PaCa immunotherapy [35]. The gene discussed is TGFB1; the disease is permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.